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Abstract
Peer review is widely used system for evaluating manuscripts prior to publication. It has been and still is widely used tool for making justified and 
fair editorial decision. However, the evidence of its efficacy is limited and it has been criticized to be time-consuming, biased, inconsistent, conser-
vative, and open to abuse. As a result, researchers, editors and policymakers have questioned its objectivity and purpose. Nevertheless, this should 
not be the reason for abandoning the principles of peer review, but to make the additional efforts towards its improvement. Therefore, this Research 
Integrity Corner aims to describe basic principles of peer review and to introduce Biochemia Medica’s guidelines for peer reviewers. Our intention is 
to help our peer reviewers provide evaluations that are as fair and objective as possible, while helping the journal publish innovative research of the 
highest quality.
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Insights into peer review
Since the very beginning of scientific publishing, 
peer review was important element for every edi-
torial decision. In the last century, the leading 
medical journals like Science, Nature and Cell de-
veloped the system into the form that is nowadays 
known (1). Yet peer review is far from perfect. It has 
been argued that it is expensive, time-consuming, 
biased, inconsistent, conservative and often 
abused. Even though many researchers, editors 
and policymakers have questioned its objectivity 
and purpose, it is still most commonly used tool 
for objective judgment of submitted manuscripts 
(2,3). Not every journal submits their manuscripts 
for peer review, though many claim to do so. A 
growing number of the so-called “predatory” 
open-access journals falsely declare themselves as 
being peer-reviewed and committed to communi-
cating high-quality research. Quite often, these 
journals require authors to pay a fee once the pa-
per is accepted for publication. To expose the 
fraud behind this process, John Bohannon submit-
ted a fabricated study with obvious errors in data 
analysis and interpretation to 304 open access 
journals under the false identity of Ocorrafoo 
Cobange. More than 60% of the journals accepted 
it, and nearly 60% of those acceptances came with 
no peer review evaluations (4). Of course, not eve-
ry open-access journal fails to submit their papers 
for rigorous peer review. Nevertheless, this experi-
ment exposed a serious flaw in peer review and 
raised numerous concerns about unethical and 
unprofessional editorial practice in great number 
of open-access journals.
These and other concerns have led some to sug-
gest that “peer review system is in crisis” (5,6). Sim-
ilar to the Bohannon experiment, Douglas Newton 
submitted similar manuscripts in several academic 
journals from the field of education. The heteroge-
neity in editor responses and reviewer comments 
led him to conclude that both reviewers and edi-
tors can be careless and biased (7).
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These concerns have helped drive research into ef-
ficacy of peer review. Some studies have suggest-
ed that younger researchers from university hospi-
tals tend to review manuscripts more rigorously 
and fairly, and that the best reviewers are research-
ers who have greater number of publications in 
high impact journals (2). However, relatively little is 
known about the overall value of peer review for 
ensuring the quality of published work (8,9).
Efforts for improvement of the existing peer re-
view system have been made in form of various 
guidelines by leading experts in scientific journal-
ism (10,11) and research ethics (12), as well as edu-
cational articles in journals (13). However, journals 
must ensure that these guidelines influence peer 
review practices, which implies the need for active 
education and guidance. To explore how often 
and in which way journals provide instructions for 
their peer reviewers, Hirst A et al. found that only 
41 of 116 health research journals (35%) posted in-
structions for their reviewers on the journal web-
site (14). Biochemia Medica supports those initia-
tives by introducing these guidelines for peer revi-
ewers in order to improve journal’s overall quality.
Ethical responsibilities of reviewers – 
existing recommendations
Some journals rely on peer review primarily as a 
means of selecting high-impact manuscripts, while 
others take a more educational approach, using 
peer reviewer assessments to improve manu-
scripts. Either way, peer review is based on mutual 
confidence among editors, reviewers and authors. 
High-quality review requires honesty and as much 
transparency as possible between editors and au-
thors. According to the Editorial Policy Committee 
of the Council of Science Editors, reviewers have 
several ethical responsibilities (10):
1. All material under review is strictly confidential. 
The reviewer should never discuss manuscripts 
with anyone without prior approval of the edi-
tor. A reviewed manuscript can be used as ma-
terial for mentoring young reviewers only with 
the editor’s permission. Every person included 
in the peer review process should be identified 
in order to receive appropriate recognition. In 
addition, the “Recommendations for the con-
duct, reporting, editing, and publication of 
scholarly work in medical journals“ of the Inter-
national Committee of Medical Journal Editors 
(ICMJE) stated that all materials received during 
the peer review process should be destroyed 
after the review is submitted to the editor (11).
2. If the reviewer feels that the manuscript goes 
beyond his expertise and that this may com-
promise the quality of his review, the reviewer 
should make that clear to the editor. Under-
taking a review without proper competence 
can have a major effect on the outcome of the 
manuscript.
3. If there is any interest that may impair objec-
tive review, the reviewer should excuse himself 
or disclose the potential conflict of interest to 
the editor, who will decide on the appropri-
ate course of action. The reviewer may also be 
asked to sign a conflict of interest form, just as 
authors do.
4. Reviewers should maintain their integrity. Their 
comments should be objective and impartial 
and should not be influenced by any personal 
data about the authors learned during the re-
view process. Reviewers should not use any in-
formation they acquire during this process for 
their personal or professional benefit.
5. When invited to review a manuscript, reviewers 
should always estimate whether the time given 
by the editor is likely to be sufficient. Reviewers 
should reply to the invitation as soon as pos-
sible, especially if they choose to decline. This 
gives the editor a chance to invite other review-
ers and does not compromise deadlines during 
the review process.
6. The reviewer’s role is not only to search for 
flaws and errors in the manuscript but also to 
point out its positive aspects and the value that 
it could provide to the journal. Every critique 
and comment should be based on objective 
evidence and include advice for improvement, 
written in a polite and constructive manner. 
Any suspicion of scientific misconduct should 
be reported to the editor and supported with 
strong arguments.
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Models of peer review
By engaging into peer review, researchers take a 
large part in author’s success and professional ad-
vancement. Peer reviewers are meant to assess 
and encourage author adherence to high standard 
of research conduct and reporting, recognize and 
prevent scientific misconduct, and remain objec-
tive and impartial at all times. Many journals blind 
the identity of reviewers and/or authors in order to 
reduce unethical behaviour and biased reviews. 
However, the influence of blinding on the quality 
of the review process is debatable (9,15). There are 
several models of blinding, each with its own per-
ceived advantages and disadvantages (Table 1) 
(3,16). Open review implies that both the reviewer 
and the author know each other’s identity. In a sin-
gle-blind review, the reviewer knows author’s 
identity, but the reviewer’s identity is concealed. 
Double-blind review means that both the reviewer 
and the author are anonymous. Some journals are 
even expanding their conception of peer review 
to take into account the fact that the true review 
process starts after the publication of the article 
(7). There are some efforts in implementation of 
post-publication review or even the combination 
of pre- and post-publication review by encourag-
ing discussion of articles through comments and 
ratings (PLoS journals, The Frontiers journals) or 
blogs (ResearchBlogging.org).
Biochemia Medica – peer review policy 
and guidelines
Biochemia Medica endorses the recommendations 
of various organizations playing a key role in pro-
moting integrity of scholarly publications: the 
Committee on Publication Ethics (COPE), the Inter-
national Committee of Medical Journal Editors (IC-
MJE), the Council of Science Editors (CSE), the Eu-
ropean Association of Science Editors (EASE), and 
CrossRef. As a result, Biochemia Medica strives to 
implement these standards through education of 
authors, readers, editors and reviewers. Our goal is 
to conduct an honest and thorough editorial proc-
ess, transparently declare our expectations from 
our reviewers, educate authors and provide high-
quality scholarly material for our readers. We be-
lieve that this is our responsibility to our readers, 
authors and reviewers, as well as to the broader 
scientific community (17,18).
The editorial process in Biochemia Medica typically 
proceeds as follows. The Editor-in-Chief screens 
manuscripts to assess their correspondence with 
the journal’s scope and to evaluate their overall 
quality. This step is crucial for eliminating manu-
scripts unlikely to pass peer review, allowing jour-
nal reviewers to focus on manuscripts with greater 
chances of success. When found suitable by the 
Editor-in-Chief, manuscripts are then analyzed by 
the Research Integrity Editor, who reports back to 
the Editor-in-Chief on text similarity analysis (19). 
This step reduces the burden on peer reviewers to 
Blinding Potential advantage Potential disadvantage
Open 
review
More objective review with constructive 
and thoughtful advice; more responsible 
engagement by the reviewer; transparency
Reviewers unwilling to review without anonymity; 
reviewers avoid giving honest critical feedback, 




Reviewers, especially young ones, can provide 
critical feedback without worrying about authors 
negative reactions or other consequences
Reviewers can be aggressive or impolite while hiding 
behind the shield of anonymity; they can deliberately 
drag out the review process for personal gain or 
engage in other types of scientific misconduct
Double-blind 
review
Prevents reviewers from bias due to the authors’ 
origins, faith or previous work especially if the 
authors are famous and influential in the field.
Perfect double blinding is rarely possible
Table 1. Perceived advantages and disadvantages of peer review blinding models (3,15,16).
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detect possible scientific misconduct, though re-
viewers are still obliged to report any misconduct 
if they suspect it. The Editor-in-Chief then assigns 
the manuscript to an Assistant Editor, who sends it 
out for peer review.
Biochemia Medica usually requires at least two 
peer reviews before making a decision about a 
submitted manuscript. More reviewers are some-
times needed, such as when the subject matter or 
statistical analysis requires additional expertise. 
Every reviewer is required to update the journal’s 
database with information about competencies 
and areas of expertise. Assistant Editors draw from 
this database to select reviewers likely to give 
high-quality review.
Biochemia Medica uses double-blind peer review. 
Therefore, as stated in the Instructions to Authors, 
the manuscript file should not contain the names 
or affiliations of the authors. All personal data 
should be reported on a separate document sub-
mitted as the title page.
Every invitation sent to the reviewer includes a 
brief explanation of his responsibilities. When re-
sponding to the invitation, each reviewer is asked 
to report any conflict of interest by emailing a 
short statement to the editorial office. The invita-
tion also contains a link to a reviewer’s check list to 
help ensure accurate and comprehensive review 
(Table 2). Since Biochemia Medica aims to educate 
authors and improve manuscript quality, review-
Table 2. Checklist for reviewers of manuscripts submitted to Biochemia Medica. This checklist is intended only to provide guidance; 
reviewers are not obliged to answer all questions, especially if they feel they lack the necessary competence.
Title
Is the title informative? Is it too long?1. 
Does it relate to the content of the article?2. 
Key words
Are the keywords appropriate? Do they reflect the content of the article? 1. 
Abstract
Is the 1. Abstract structured?
Is there an aim and a hypothesis?2. 
Do the authors list the number of patients/groups and study design?3. 
Do the authors provide their key results (with numbers and P values)?4. 
Is the conclusion based on the results of the study?5. 
Is the conclusion in the 6. Abstract identical to the conclusion at the end of the Discussion?
Introduction
Do the authors explain the background of the problem?1. 
Do the authors list recent relevant studies?2. 
Do the authors clearly elaborate their hypothesis?3. 
Does the study have novelty?4. 
Is there a clear and unambiguous aim at the end of the 5. Introduction?
Materials and methods
Is the 1. Materials and methods section structured?
Are the following subheading used (if applicable): 2. Study design, Subjects, Blood sampling, Methods, Statistical analysis?
Subjects
Do the authors correctly indicate the type of study (e.g. observational, prospective, retrospective, diagnostic accuracy, 1. 
analytical validation)?
Do the authors follow the recommended reporting guidelines for their type of study (available at http://www.equator-network.org/)?2. 
Do the authors indicate the number of groups and patients within groups?3. 
Are precise inclusion and exclusion criteria provided?4. 
Are criteria for diseases and conditions clearly defined and referenced (if applicable)?5. 
Is the control group described in sufficient detail?6. 
Is the method of recruitment described adequately?7. 
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Do the authors clearly state how they determined the absence of disease in control individuals?8. 
Did study participants sign informed consent?9. 
Was the study approved by the relevant institutional ethical committee? 10. 
Blood sampling
Was blood sampling performed in the fasting state?1. 
What tubes, additives and volumes were used? Additive? Volume?2. 
How many tubes were used?3. 
Was testing performed immediately or were samples aliquoted and stored? 4. 
Methods
Is manufacturer information provided for all reagents and equipment used?1. 
Do the authors list all tests performed in the study? Were all the tests listed in the 2. Materials and Methods section actually 
performed, and are results provided in the Results section?
Are the methods explained in sufficient detail?3. 
Are any non-standard methods described in sufficient detail?4. 
Is CV provided for non-standard methods, such as ELISA assays, new biomarkers, or assays for specific proteins? Do the authors 5. 
clearly state whether the CV they report is based on manufacturer specifications or their own measurements?
Are QC measures explained (if applicable)?6. 
Statistical analysis
Have all data sets been tested for normality, ad is the name of the normality test provided?1. 
Do the authors list all the tests used?2. 
Do the authors explain their rationale for using different tests?3. 
Is the level of statistical significance provided?4. 
Are the name, version and manufacturer of statistical programs provided?5. 
Results
Is the statistical analysis appropriate? Are the correct statistical tests used?1. 
Are summary data provided as mean ± SD for normal distributions (if ≥30 subjects)?2. 
Are summary data provided as median (Q1-Q3) for non-normal distributions (if <30 subjects)?3. 
Is age provided as median (min-max)?4. 
Are the tests mentioned in the 5. Results the same as those listed in the Statistical analysis section of Materials and Methods?
Do the authors explain any missing values?6. 
Do the authors provide P values for all tested differences?7. 
Do the authors repeat their results in tables and in the text?8. 
Are the tables informative? Are column and row titles logical and informative?9. 
Do the authors refrain from using percentage if there are fewer than 100 subjects?10. 
Do the authors refrain from using expressions like “effect” and “cause” if they have not performed an experiment? In the case of 11. 
an observational study without intervention, do the authors limit themselves to talking only about associations?
Do the authors refrain from using expressions like “decline” and “increase” to describe the differences in concentrations 12. 
between groups, and instead use those terms only to describe changes of one group through multiple measurements over 
a period of time? If the study is observational (whether case-control or cross-sectional), do the authors limit themselves to 
indicating only whether there is a difference between groups?
Discussion
Does the 1. Discussion start by listing the key results of the study?
Do the authors comment on their results and how they support or fail to support their hypothesis?2. 
Do the authors discuss other studies and how they relate to their findings?3. 
Do the authors discuss causal relationship only if their study was interventional and otherwise limit themselves to talking only 4. 
about associations?
Do the authors indicate the added value of their work? Do they indicate what is new in their study and why this study is important?5. 
Do the authors clearly describe the limitations of their study?6. 
Do the authors draw clear and unambiguous conclusions based solely on their results?7. 
Do the conclusions go beyond the results of the study?8. 
Is the 9. Conclusion is identical to the Conclusion part of the Abstract?
References
Are the references up-to-date?1. 
Are the references formatted according to journal style?2. 
Are references numbered consecutively in the manuscript?3. 
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ers are encouraged to write detailed reviews with 
thorough explanations whenever possible. 
When receiving an invitation from Biochemia 
Medica, the reviewer is supposed to:
Read the manuscript abstract included in the •	
invitation in order to evaluate whether the re-
viewer has the necessary expertise in the sub-
ject area involved. The reviewer should accept 
or reject the invitation as soon as possible. If for 
any reason, during the review process, the re-
viewer feels he has insufficient expertise to 
handle the manuscript, the reviewer should in-
form the editor promptly.
Respect the deadline for responding to the in-•	
vitation as well as the deadline for submitting 
the review. Failing to respect these deadlines is 
considered a lack of professional courtesy. Re-
viewers should contact the editors promptly if 
they require an extension.
Declare any possible conflict of interest to the •	
editor. If potential conflicts of interest appear 
during the review process, they should be re-
ported accordingly.
Keep all materials provided by the journal strict-•	
ly confidential. The editor must approve any 
sharing of the material with a third person. All 
persons involved in conducting the review 
should be properly identified.
When writing a review, the reviewer is sup-
posed to:
Read the Journal’s scope and •	 Instructions to Au-
thors in order to write the review with journal 
objectives and format guidelines in mind.
Consult the journal’s •	 Guidelines for Reviewers.
Evaluate the manuscript objectively and impar-•	
tially. Perfect blinding of the manuscript is not 
always possible; sometimes personal informa-
tion about the author or the author’s institution 
can be surmised from the manuscript content.
Notify the editor about any doubt in the integ-•	
rity of the manuscript content or conduct of the 
study. The reviewer should never investigate 
potential misconduct by himself.
State the overall recommendations for the •	
manuscript: accept, accept after minor modifi-
cations, accept after major modifications, re-
ject.
Provide additional comments according to the •	
Journal’s checklist (Table 2). The checklist is 
aimed to prevent the omission of important is-
sues and to help reviewers structure their re-
ports. The checklist is only for guidance; review-
ers are not obliged to answer all the questions, 
especially if they do not feel competent to do 
so.
Summarize all the positive findings of the man-•	
uscript that could provide value to the journal.
Write every criticism or comment in clear, con-•	
cise and polite language. State the exact sen-
tence in question by citing page number, text 
line or paragraph. For example: “Page 4, line 14: 
instead of ’preanalytical warnings’ the author 
could consider using the phrase ‘preanalytical 
recommendations’.”
Follow up all criticisms with explanation and •	
advice for correction. If appropriate, comments 
should be supported with evidence from the 
literature. For example, instead of merely stat-
ing “The statistical test used in the text is 
wrong.” consider giving an explanation with 
advice for further reading: ”Correlation is not 
tested using the appropriate statistical test. The 
statistical test for correlation depends on sam-
ple size and normality of data distribution. For 
large samples and normally distributed data, 
the Pearson correlation test should be used. In 
the case of a small sample or deviation from 
normal data distribution, consider using the 
Spearman correlation test.”
Never address the author personally, make any •	
improper comments or use aggressive terms. 
Moreover, it is highly inappropriate to use capi-
tal letters, exclamation marks or direct verbal 
insults. For example, instead of “THIS STATE-
MENT MAKES NO SENSE!!!”, it is much better to 
write: “The authors may consider rephrasing 
the sentence.”
Strive to make the review educational so the •	
author can learn from his mistakes and improve 
the manuscript as much as possible. Instead of 
criticizing the Discussion section of the manu-
script, try to explain the proper way for discuss-
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ing the results, such as: “To improve the Discus-
sion I suggest that authors start with their key 
findings, discuss their results in comparison 
with existing data in the literature, and explain 
how their results fit into what’s already known. I 
also strongly suggest that authors emphasize 
the added value of their results and the novelty 
of the study.”
Inform the editor about all limitations of the re-•	
view in the section “Confidential comments to 
the editor”, such as if the reviewer does not feel 
confident enough to review the statistical anal-
yses.
After submitting the review, the reviewer is 
supposed to:
Destroy all copies of the reviewed manuscript •	
in order to maintain confidentiality.
Refrain from using any information acquired •	
during the review process until after the article 
has been published.
Read the reviews of other reviewers and con-•	
tact the editor if additional comments are nec-
essary.
Conclusion
Each published article is a combined effort of the 
authors, editors and reviewers, each of whom has 
his own responsibilities. The reviewer’s responsi-
bility is to analyze the manuscript objectively and 
thoroughly and to provide useful advice and con-
structive comments to the author. Reviewers con-
tribute significantly to the final editorial decision, 
but to do so properly, they should be honest and 
fair in their evaluations. Peer reviewers indeed car-
ry great responsibility despite working for the jour-
nals as volunteers, but this noble activity does pro-
vide some benefits. Having the privilege of read-
ing the “unknown” is thrilling, and helping to 
shape new information for presentation to the 
broader community provides a sense of impor-
tance. Reviewers also derive professional benefits: 
in many countries, including Croatia, peer review 
activities are taken into account for professional 
advancement in academic career. To ensure that 
the work of reviewers is recognized, Biochemia 
Medica publishes, at the end of the year, the list of 
reviewers who contributed to the journal.
Reviewers play a fundamental role in maintaining 
the quality of research publications and how they 
are implemented in everyday lives. We thank all 
our reviewers for investing their time, effort and 
expertise in our journal. The editorial work, though 
demanding by itself, would be almost impossible 
without the valuable contribution of peer review-
ers.
Potential conflict of interest
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